Novasep Appoints New President of Synthesis Business Unit - - BioPharm International

ADVERTISEMENT

Novasep Appoints New President of Synthesis Business Unit



Novasep, a supplier of manufacturing solutions to the life sciences industry, has appointed Thierry van Nieuwenhove as president of the synthesis business unit.
Van Nieuwenhove holds a Master's degree in chemistry and biochemistry from the Catholic University of Louvain, Belgium. Van Nieuwenhove joins Novasep from Ajinomoto-Omnichem, a European synthetic molecules custom manufacturing organization, where he held positions as director, general manager, and member of the board.

Source: Novasep

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Pfizer to Acquire Vaccines from Baxter
July 30, 2014
GSK Submits EU Regulatory Filing for Malaria Vaccine Candidate
July 29, 2014
Bristol-Myers Squibb and Ono Pharmaceutical Collaborate on Immunotherapies
July 28, 2014
FDA Accepts First Biosimilar Filing
July 24, 2014
Compounding Pharmacy Issues Recall, But Challenges FDA Decision
July 22, 2014
Author Guidelines

Click here